Immune Effects of γδ T Cells in Colorectal Cancer: A Review

被引:27
|
作者
Ma, Rulan [1 ]
Yuan, Dawei [1 ]
Guo, Yizhan [2 ]
Yan, Rong [1 ]
Li, Kang [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Xian, Peoples R China
[2] Univ Virginia, Dept Surg, Charlottesville, VA USA
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
关键词
gamma delta T cells; colorectal cancer; antitumor effects; protumor effects; immunotherapy; INFLAMMATORY-BOWEL-DISEASE; ANTITUMOR-ACTIVITY; TUMOR MICROENVIRONMENT; ADOPTIVE TRANSFER; ZOLEDRONIC ACID; IMMUNOTHERAPY; RECEPTOR; MODEL; IL-17; SURVIVAL;
D O I
10.3389/fimmu.2020.01600
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gamma delta (gamma delta) T cells can effectively recognize and kill colorectal cancer (CRC) cells, thereby suppressing tumor progressionviamultiple mechanisms. They also have abilities to exert a protumor effectviasecreting interleukin-17 (IL-17). gamma delta T cells have been selected as potential immunocytes for antitumor treatment because of their significant cytotoxic activity. Immunotherapy is another potential anti-CRC strategy after an operation, chemotherapy, and radiotherapy. gamma delta T cell-based immunotherapy for CRC shows fewer side effects and better toleration. This review will outline the immune functions and the mechanisms of gamma delta T cells in the growth and progression of CRC in recent years, and summarize the immunotherapies based on gamma delta T cells, thus providing a direction for future gamma delta T cells in CRC research.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Assessment of immune T cells expression in colorectal cancer
    Boujelbene, N.
    Zemni, I.
    Dhouioui, S.
    Ben Yahia, H.
    Babay, W.
    Ben Mansour, A.
    Mrad, K.
    Ouzari, H.
    Zidi, I.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S92 - S93
  • [2] Immune cells in colorectal cancer
    Wolf, D
    Marth, C
    Wolf, AM
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1531 - 1531
  • [3] The role of CD8+ T cells in immune responses to colorectal cancer
    Liviu V. Titu
    John R. Monson
    John Greenman
    Cancer Immunology, Immunotherapy, 2002, 51 : 235 - 247
  • [4] The role of CD8+ T cells in immune responses to colorectal cancer
    Titu, LV
    Monson, JRT
    Greenman, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (05) : 235 - 247
  • [5] Review article: immune suppression and colorectal cancer
    Evans, C.
    Dalgleish, A. G.
    Kumar, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (08) : 1163 - 1177
  • [6] Engineered T cells for Colorectal Cancer
    Bakarurraini, Nurul Ainaa Adilah Rus
    Kamarudin, Ammar Akram
    Jamal, Rahman
    Abu, Nadiah
    IMMUNOTHERAPY, 2024,
  • [7] Cancer stem cells in colorectal cancer: a review
    Munro, Matthew J.
    Wickremesekera, Susrutha K.
    Peng, Lifeng
    Tan, Swee T.
    Itinteang, Tinte
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (02) : 110 - 116
  • [8] The effects of metabolism on the immune microenvironment in colorectal cancer
    Xingzhao Chen
    Zhiyuan Ma
    Zhiqiang Yi
    Enqin Wu
    Zhengye Shang
    Biguang Tuo
    Taolang Li
    Xuemei Liu
    Cell Death Discovery, 10
  • [9] The effects of metabolism on the immune microenvironment in colorectal cancer
    Chen, Xingzhao
    Ma, Zhiyuan
    Yi, Zhiqiang
    Wu, Enqin
    Shang, Zhengye
    Tuo, Biguang
    Li, Taolang
    Liu, Xuemei
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [10] Effect of obesity on CD4+T cells in the tumor immune microenvironment of colorectal cancer
    Ando, Masayuki
    Yamada, Kota
    Saito, Masafumi
    Yamashita, Kimihiro
    Tsuneki, Takao
    Adachi, Yuri
    Abe, Tomoki
    Mukoyama, Tomosuke
    Sawada, Ryuichiro
    Koterazawa, Yasufumi
    Harada, Hitoshi
    Urakawa, Naoki
    Goto, Hironobu
    Hasegawa, Hiroshi
    Kanaji, Shingo
    Matsuda, Takeru
    Kakeji, Yoshihiro
    CANCER RESEARCH, 2024, 84 (06)